T1	Participants 214 244	patients with major depression
T2	Participants 471 519	patients who participated in the STOPD-PD study,
T3	Participants 910 1045	subjects with a history of no prior treatment or inadequate treatment who were treated with a combination of olanzapine and sertraline.
T4	Participants 1083 1204	subjects who had previously failed to respond to an antidepressant alone and who were treated with olanzapine monotherapy
T5	Participants 1248 1352	subjects who had previously failed to respond to a combination of an antipsychotic and an antidepressant
T6	Participants 1482 1502	patients with MDpsy.
